Mechanisms of Hippo signaling in Alcoholic liver disease
Hippo 信号在酒精性肝病中的机制
基本信息
- 批准号:9532021
- 负责人:
- 金额:$ 20.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-20 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alcohol consumptionAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholic liver damageAlcoholsAttenuatedCell DeathChronicCirrhosisDataDiseaseDown-RegulationDrosophila genusEthanolFoundationsGeneticGoalsHepatocyteImpairmentIn VitroInfiltrationInflammationInflammatoryInjuryInnate Immune ResponseInvestigationKnowledgeLeadLiverLiver FailureLiver RegenerationMammalsMediatingModelingMolecularMorbidity - disease rateNatural regenerationOxidative StressPathogenesisPathway interactionsPatientsPhosphotransferasesPlayPrimary carcinoma of the liver cellsProductionProteinsRegulationResearchResearch PersonnelRoleSignal PathwaySignal TransductionSolidSteatohepatitisTLR4 geneTherapeuticTissuesadaptive immune responsealcohol abuse therapyalcohol effectchronic alcohol ingestioncytokinecytotoxicdriving forcefeedingin vivoliver cell proliferationliver inflammationliver injurymacrophagemortalitymouse modelmutantproblem drinkerrestorationtranscription factor
项目摘要
Alcoholic liver disease (ALD), a major cause of morbidity and mortality worldwide, includes a broad spectrum
of disorders, ranging from simple steatosis to severe forms of liver injury such as steatohepatitis, alcoholic
hepatitis, cirrhosis, liver failure and hepatocellular carcinoma. Aside from the direct cytotoxic and the oxidative-
stress–mediated effects that alcohol and its metabolites exert on hepatocytes, alcohol ingestion also activates
both the innate and adaptive immune responses in the liver, and dysregulates several important signaling
pathways in the liver, thereby contributing to the pathogenesis of ALD. Recent studies suggest that impaired
liver regeneration and inflammation are two important mechanisms contributing to liver failure in patients with
alcoholic hepatitis. However, the underlying mechanisms remain unclear. The Hippo (Hpo) signaling pathway
has recently emerged as a critical one regulating hepatocyte proliferation, survival as well as inflammation.
Central to the Hpo pathway is the control of Yap/Taz transcription factors by a kinase cascade starting from the
Hpo kinase, which are Mst1 and Mst2 in mammals. As hepatocyte injury is a major driving force for ALD
pathogenesis, the goal of this explorative R21 proposal is to determine whether alcohol attenuates liver
regeneration and induces liver inflammation by dysregulating the Hpo signaling pathway in hepatocytes.
Despite the critical functions of Hpo signaling in restricting hepatocyte proliferation and survival we and others
have identified, the precise functions and molecular mechanisms whereby the Hpo signaling pathway
participates in alcohol-induced liver injury, inflammation and regeneration are mostly unknown. Hence, there
are many unanswered fundamental questions regarding Hpo signaling in ALD. The knowledge gained from the
proposed studies will establish a solid new foundation for further mechanistic investigation of Hpo signaling in
ALD and provide new targets and strategies to protect liver from alcohol induced injury. Our unpublished
preliminary data show that in a short-term chronic-binge ALD (E1d-1B) model, Mst1, Mst2 and Yap protein
levels were reduced. We have also found that, infiltrated macrophage numbers and expression of pro-
inflammatory cytokines are increased in the hepatocyte-specific Mst1 and Mst2 double mutant (DKO) liver. We
hypothesize that reduction in Yap expression leads to increased hepatocyte cell death and impaired
hepatocyte regeneration; while Mst1 and Mst2 down-regulation in hepatocytes of the alcoholic liver contributes
to chronic pro-injury liver inflammation. In Specific Aim 1, we will define the effects of alcohol consumption on
the Hpo signaling pathway in hepatocytes. In Specific Aim 2, we will determine whether alcohol feeding inhibits
liver regeneration by reducing Yap in hepatocytes. In Specific Aim 3, we will determine whether alcohol feeding
causes liver inflammation by reducing Mst1 and Mst2 in hepatocytes.
酒精性肝病(ALD)是世界范围内发病率和死亡率的主要原因,
从简单的脂肪变性到严重形式的肝损伤,如脂肪性肝炎、酒精性肝炎、
肝炎、肝硬化、肝衰竭和肝细胞癌。除了直接的细胞毒性和氧化-
酒精及其代谢产物对肝细胞的应激介导作用,酒精摄入也激活
肝脏中的先天性和适应性免疫反应,并失调几个重要的信号传导
肝脏中的通路,从而有助于ALD的发病机制。最近的研究表明,
肝再生和炎症是导致肝衰竭的两个重要机制,
酒精性肝炎然而,其潜在机制仍不清楚。Hippo(Hpo)信号通路
最近已经成为调节肝细胞增殖、存活以及炎症的关键因子。
Hpo途径的中心是通过激酶级联反应控制雅普/Taz转录因子,所述激酶级联反应起始于
Hpo激酶,在哺乳动物中为Mst 1和Mst 2。由于肝细胞损伤是ALD的主要驱动力
发病机制,这个探索性的R21建议的目标是确定酒精是否会削弱肝脏
肝细胞中的Hpo信号通路失调,导致肝脏再生并诱导肝脏炎症。
尽管Hpo信号传导在限制肝细胞增殖和存活中起着关键作用,
已经确定了Hpo信号通路的精确功能和分子机制,
参与酒精诱导的肝损伤,炎症和再生大多是未知的。因此,在那里
关于ALD中的Hpo信号传导有许多未回答的基本问题。知识来自于
提出的研究将为进一步研究Hpo信号转导机制奠定坚实的新基础。
为酒精性肝损伤的防治提供了新的靶点和策略.我们未发表
初步数据显示,在短期慢性酒精性肝病(E1 d-1B)模型中,Mst 1、Mst 2和雅普蛋白
水平降低了。我们还发现,浸润的巨噬细胞数量和前体细胞的表达,
炎性细胞因子在肝细胞特异性Mst 1和Mst 2双突变体(DKO)肝脏中增加。我们
假设雅普表达减少导致肝细胞死亡增加和受损
肝细胞再生;而酒精肝肝细胞中Mst 1和Mst 2的下调有助于肝细胞再生
慢性损伤性肝脏炎症在具体目标1中,我们将定义饮酒对
肝细胞中的Hpo信号通路。在具体目标2中,我们将确定酒精喂养是否会抑制
通过减少肝细胞中的雅普来促进肝再生。在具体目标3中,我们将确定酒精喂养是否
通过减少肝细胞中的Mst 1和Mst 2引起肝脏炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yingzi Yang其他文献
Yingzi Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yingzi Yang', 18)}}的其他基金
Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Hippo信号抑制肝脏肿瘤形成的细胞和分子机制
- 批准号:
10216195 - 财政年份:2018
- 资助金额:
$ 20.13万 - 项目类别:
Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Hippo信号抑制肝脏肿瘤形成的细胞和分子机制
- 批准号:
10449975 - 财政年份:2018
- 资助金额:
$ 20.13万 - 项目类别:
Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Hippo信号抑制肝脏肿瘤形成的细胞和分子机制
- 批准号:
9978754 - 财政年份:2018
- 资助金额:
$ 20.13万 - 项目类别:
Mechanisms of Hippo signaling in Alcoholic liver disease
Hippo 信号在酒精性肝病中的机制
- 批准号:
9296288 - 财政年份:2017
- 资助金额:
$ 20.13万 - 项目类别:
Molecular Mechanism of Wnt/Planar Cell Polarity Signaling
Wnt/平面细胞极性信号传导的分子机制
- 批准号:
9219069 - 财政年份:2017
- 资助金额:
$ 20.13万 - 项目类别:
Molecular Mechanism of Wnt/Planar Cell Polarity Signaling
Wnt/平面细胞极性信号传导的分子机制
- 批准号:
10288018 - 财政年份:2017
- 资助金额:
$ 20.13万 - 项目类别:
Gas-Hedgehog signaling in intramembranous bone formation and expansion
Gas-Hedgehog 信号在膜内骨形成和扩张中的作用
- 批准号:
9977003 - 财政年份:2016
- 资助金额:
$ 20.13万 - 项目类别:
Gas-Hedgehog signaling in intramembranous bone formation and expansion
Gas-Hedgehog 信号在膜内骨形成和扩张中的作用
- 批准号:
9191649 - 财政年份:2016
- 资助金额:
$ 20.13万 - 项目类别:
Cxcl12-Hedgehog signaling in cranial bone regeneration
颅骨再生中的 Cxcl12-Hedgehog 信号传导
- 批准号:
10657799 - 财政年份:2016
- 资助金额:
$ 20.13万 - 项目类别:
Gas-Hedgehog signaling in intramembranous bone formation and expansion
Gas-Hedgehog 信号在膜内骨形成和扩张中的作用
- 批准号:
9310346 - 财政年份:2016
- 资助金额:
$ 20.13万 - 项目类别:
相似海外基金
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
- 批准号:
10527603 - 财政年份:2022
- 资助金额:
$ 20.13万 - 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
- 批准号:
10686094 - 财政年份:2022
- 资助金额:
$ 20.13万 - 项目类别:
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis
一种创新的非噻唑烷二酮类泛 PPAR 激动剂,用于治疗酒精性肝炎
- 批准号:
10482468 - 财政年份:2022
- 资助金额:
$ 20.13万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10298412 - 财政年份:2021
- 资助金额:
$ 20.13万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10494268 - 财政年份:2021
- 资助金额:
$ 20.13万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10617893 - 财政年份:2021
- 资助金额:
$ 20.13万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10646369 - 财政年份:2021
- 资助金额:
$ 20.13万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10874892 - 财政年份:2021
- 资助金额:
$ 20.13万 - 项目类别: